- Home
- DCTH vs CLW Comparison
DCTH vs CLW Comparison
Compare DCTH & CLW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DCTH
- CLW
- Stock Information
- Founded
- DCTH 1988
- CLW 2005
- Country
- DCTH United States
- CLW United States
- Employees
- DCTH N/A
- CLW N/A
- Industry
- DCTH Medical/Dental Instruments
- CLW Paper
- Sector
- DCTH Health Care
- CLW Basic Materials
- Exchange
- DCTH Nasdaq
- CLW Nasdaq
- Market Cap
- DCTH 518.0M
- CLW 481.8M
- IPO Year
- DCTH N/A
- CLW N/A
- Fundamental
- Price
- DCTH $14.88
- CLW $27.30
- Analyst Decision
- DCTH Strong Buy
- CLW Buy
- Analyst Count
- DCTH 4
- CLW 1
- Target Price
- DCTH $22.25
- CLW $37.00
- AVG Volume (30 Days)
- DCTH 356.0K
- CLW 301.0K
- Earning Date
- DCTH 03-06-2025
- CLW 02-13-2025
- Dividend Yield
- DCTH N/A
- CLW N/A
- EPS Growth
- DCTH N/A
- CLW 85.68
- EPS
- DCTH N/A
- CLW 11.70
- Revenue
- DCTH $22,644,000.00
- CLW $1,383,600,000.00
- Revenue This Year
- DCTH $1,672.40
- CLW $14.27
- Revenue Next Year
- DCTH $116.33
- CLW N/A
- P/E Ratio
- DCTH N/A
- CLW $2.30
- Revenue Growth
- DCTH 945.91
- CLW N/A
- 52 Week Low
- DCTH $3.70
- CLW $23.97
- 52 Week High
- DCTH $16.97
- CLW $57.13
- Technical
- Relative Strength Index (RSI)
- DCTH 46.47
- CLW 39.33
- Support Level
- DCTH $15.50
- CLW $25.38
- Resistance Level
- DCTH $16.43
- CLW $32.55
- Average True Range (ATR)
- DCTH 0.72
- CLW 1.19
- MACD
- DCTH -0.25
- CLW -0.44
- Stochastic Oscillator
- DCTH 2.79
- CLW 26.78
About DCTH Delcath Systems Inc.
Delcath Systems Inc is an oncology company. It is focused on the treatment of primary and metastatic liver cancers. The firm's product, Melphalan Hydrochloride for Injection along with the Delcath Hepatic Delivery System, or Melphalan/HDS, is a drug and device combination product, designed to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects.
About CLW Clearwater Paper Corporation
Clearwater Paper Corp is engaged in the manufacturing and selling of private label tissue, paperboard, and pulp-based products. The company has two reportable segments namely the consumer products segment which manufactures and sells a complete line of at-home tissue products as well as AFH products. The pulp and paperboard segment manufactures and markets bleached paperboard for the high-end segment of the packaging industry as well as offers services that include custom sheeting, slitting and cutting of paperboard. It generates maximum revenue from Pulp and Paperboard segment. Geographically, it derives maximum revenue from the United States.